|
The ABL Advisor Deal Tables
SELECTED TRANSACTION DETAILS
Liquidia Secures $20.5MM Debt Facility with Silicon Valley Bank
|
Lenders/Participants
|
Silicon Valley Bank [Lender]
|
|
Structure
|
Debt Facility
|
|
Amount
|
$20.500
Million
|
|
Borrower(s)
|
Liquidia Corporation
|
|
Description
|
Under the terms of the debt facility, Silicon Valley Bank will make loans available in three tranches. Proceeds from the first tranche of $10.5 million have been used to retire Liquidia’s existing term debt with Pacific Western Bank and adds approximately $1.0 million to Liquidia’s balance sheet. A second tranche of $5.0 million is available upon the Food and Drug Administration (FDA) granting Liquidia tentative approval for LIQ861 by June 30, 2022, and the third tranche of $5.0 million is available upon receipt of final and unconditional approval for LIQ861 by December 31, 2022. The debt facility will mature on September 1, 2024 and will consist of interest-only payments through March 31, 2023.
|
|
Industry
|
Life Sciences
|
| Related Tags |
Silicon Valley Bank
|
ABL Advisor
Deal Tables
2024
|
|
|
|